Cancer drug developer ViraTherapeutics has been acquired by Boehringer Ingelheim, three years after the corporate led its series A round.
Author: Thierry Heles
Epic applies itself to $52m series E
Oncology diagnostics technology developer Epic Sciences, whose investors include Genomic Health, Pfizer and Roche, has now raised at least $135m in total.
Westwing to take flight in $139m IPO
Rocket Internet-backed online furniture retailer Westwing aims to raise $139m in an initial public offering in Frankfurt.
Main Sequence rearranges fund to reach $167m
Lockheed Martin was among the limited partners that helped Main Sequence Ventures add almost $95m to its Csiro Innovation Fund 1.
Kissht consumes $30m
Sistema Asia Fund and Vertex Ventures co-led a $30m series C round for buy now, pay later service Kissht that included existing investor Fosun.
Imec attracts corporates to close fund at $135m
Samsung, Philips, Applied Materials, SK Hynix, KBC, Belfius, BNP Paribas Fortis and KPN Ventures have all backed the Imec.xpand fund.
Chain tethers to Lightyear to go Interstellar
Chain, a blockchain technology provider backed by Visa, Orange, Fiserv, Nasdaq, Citi and Capital One, has merged with Lightyear to form a new company dubbed Interstellar.
PingCap indexes $50m series C
Fosun has co-led a $50m series C round for cloud-based database developer PingCap, which will use the money to drive global growth and technology development.
How to lose the innovation arms race
Brazil, China, Singapore, Israel and India have been hailed as the most effective patenting nations between 2005 and 2015. The US-based Centre for Advancing Innovation, a non-profit that aims to accelerate tech transfer, and intellectual property analytics and management platform PatSnap have produced The Innovation Arms Race 2018 report – but it is bad news… Continue reading How to lose the innovation arms race
Cigna makes Cricket match in $24m series A
Cricket Health, developer of an integrated kidney care service that helps patients stay out of hospital, has completed an Oak HC/FT-led series A round.
ShipBob handles $40m series C delivery
Recruit-backed e-commerce fulfilment services provider ShipBob increased its total funding to more than $62m in a round led by Menlo Ventures.
Twentyeight-Seven counts down to $65m series A
Novartis Venture Fund, a founding investor, co-led a $65m series A round to launch cancer treatment developer Twentyeight-Seven Therapeutics.
MasterClass addresses $80m series D
Evolution Media has put its weight behind MasterClass, an online education provider already backed by Bloomberg and Novel Group.
Dream11 wakes up to $100m series D
Tencent has led a $100m series D round for fantasy sports company Dream11, a deal that was first rumoured in April this year.